Answer:
The new drug appears to reduce insomnia since the re-randomized mean differences are close to the mean difference found between the two groups studied.
Step-by-step explanation:
The group given the new drug reported an average of 3.3 nights they suffered insomnia a month. Therefore the mean of this group is 3.3.
On the other hand, the control group receiving the placebo reported an average of 9.5 nights they suffered insomnia a month. Therefore, the mean of this control group is 9.5.
The population mean difference between these two groups is thus;
9.5 - 3.3 = 6.2
This difference is very significant inferring that the new drug appears to reduce insomnia. Nevertheless, this mean difference is considerably close to the difference of the means from re randomization. Therefore we can conclude that,
The new drug appears to reduce insomnia since the re-randomized mean differences are close to the mean difference found between the two groups studied.
